scientific article; zbMATH DE number 5224906

MaRDI QIDQ5434036zbMATH OpenFDO

Authors Yuan Ji, Yisheng Li, Guosheng Yin

Publication date 9 January 2008

zbMATH Keywords

Markov chain Monte Carlosimulationsstopping rulepenaltytoxicitystochastic moves

Mathematics Subject Classification ID

Bayesian inference (62F15) Applications of statistics to biology and medical sciences; meta analysis (62P10) Monte Carlo methods (65C05) Numerical analysis or methods applied to Markov chains (65C40) Optimal stopping in statistics (62L15)

Recommendations

• Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios
• Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design
• A Bayesian Approach to the Design of Phase II Clinical Trials
• scientific article; zbMATH DE number 4155731
• Bayesian designs for phase I--II clinical trials
• Bayesian design for clinical trials with a constraint on the total available dose
• Bayesian optimal designs for phase I clinical trials

Cited in

(15)

• Bayesian models and decision algorithms for complex early phase clinical trials
• The treatment versus experimentation dilemma in dose finding studies
• Bayesian dose finding for combined drugs with discrete and continuous doses
• Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors
• Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics
• Dose Finding – A Challenge in Statistics
• Stochastic approximation with virtual observations for dose-finding on discrete levels
• DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment courses
• Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
• A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials
• Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design
• Adaptive clinical trial designs for phase I cancer studies
• Bayesian hierarchical random-effects meta-analysis and design of phase I clinical trials
• An application of reinforced urn processes to determining maximum tolerated dose
• Bayesian decision procedures based on logistic regression models for dose-finding studies

This page was built for publication:

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5434036)